IL267191B2 - Use of a carbamate compound to prevent, relieve or treat tremors or tremor syndrome - Google Patents
Use of a carbamate compound to prevent, relieve or treat tremors or tremor syndromeInfo
- Publication number
- IL267191B2 IL267191B2 IL267191A IL26719119A IL267191B2 IL 267191 B2 IL267191 B2 IL 267191B2 IL 267191 A IL267191 A IL 267191A IL 26719119 A IL26719119 A IL 26719119A IL 267191 B2 IL267191 B2 IL 267191B2
- Authority
- IL
- Israel
- Prior art keywords
- tremor
- syndrome
- formula
- carbamate compound
- group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160170225 | 2016-12-14 | ||
| PCT/KR2017/014743 WO2018111009A1 (ko) | 2016-12-14 | 2017-12-14 | 진전 또는 진전 증후군의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL267191A IL267191A (enExample) | 2019-07-31 |
| IL267191B1 IL267191B1 (en) | 2023-01-01 |
| IL267191B2 true IL267191B2 (en) | 2023-05-01 |
Family
ID=62558966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL267191A IL267191B2 (en) | 2016-12-14 | 2019-06-10 | Use of a carbamate compound to prevent, relieve or treat tremors or tremor syndrome |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11033531B2 (enExample) |
| EP (1) | EP3556364B1 (enExample) |
| JP (1) | JP7086076B2 (enExample) |
| KR (1) | KR102635941B1 (enExample) |
| CN (1) | CN110267657B (enExample) |
| AU (1) | AU2017374459B2 (enExample) |
| CL (1) | CL2019001623A1 (enExample) |
| ES (1) | ES3039979T3 (enExample) |
| IL (1) | IL267191B2 (enExample) |
| MX (1) | MX391363B (enExample) |
| MY (1) | MY198417A (enExample) |
| WO (1) | WO2018111009A1 (enExample) |
| ZA (1) | ZA201903749B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2973111T3 (es) * | 2017-11-14 | 2024-06-18 | Sk Biopharmaceuticals Co Ltd | Uso de un compuesto de carbamato para prevenir o tratar enfermedades asociadas con el aumento de la corriente tardía de sodio |
| IL281559B2 (en) * | 2018-09-21 | 2025-06-01 | Sk Biopharmaceuticals Co Ltd | (r)-1-phenyl-2-tetrazolyl ethyl carbamate derivatives and formulations comprising same for use in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002067926A1 (en) * | 2001-02-27 | 2002-09-06 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating movement disorders |
| WO2006112685A1 (en) * | 2005-04-22 | 2006-10-26 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| WO2014142518A1 (en) * | 2013-03-12 | 2014-09-18 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in preventing or treating a movement disorder |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005097136A1 (en) * | 2004-03-29 | 2005-10-20 | Merck & Co., Inc. | Biaryl substituted pyrazinones as sodium channel blockers |
| EP2114393B1 (en) * | 2007-03-05 | 2013-04-17 | Indus Biotech Private Limited | Pharmaceutical compositions comprising trigonelline and 4-hydroxyisoleucine and a process thereof |
| AU2009348523B2 (en) * | 2009-06-22 | 2015-02-26 | Sk Biopharmaceuticals Co., Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| US8404461B2 (en) | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| KR102489052B1 (ko) * | 2016-05-19 | 2023-01-16 | 에스케이바이오팜 주식회사 | 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
-
2017
- 2017-12-14 KR KR1020197018409A patent/KR102635941B1/ko active Active
- 2017-12-14 JP JP2019531817A patent/JP7086076B2/ja active Active
- 2017-12-14 EP EP17880232.8A patent/EP3556364B1/en active Active
- 2017-12-14 ES ES17880232T patent/ES3039979T3/es active Active
- 2017-12-14 MY MYPI2019003351A patent/MY198417A/en unknown
- 2017-12-14 MX MX2019006941A patent/MX391363B/es unknown
- 2017-12-14 CN CN201780077642.3A patent/CN110267657B/zh active Active
- 2017-12-14 WO PCT/KR2017/014743 patent/WO2018111009A1/ko not_active Ceased
- 2017-12-14 AU AU2017374459A patent/AU2017374459B2/en active Active
- 2017-12-14 US US16/468,936 patent/US11033531B2/en active Active
-
2019
- 2019-06-10 IL IL267191A patent/IL267191B2/en unknown
- 2019-06-11 ZA ZA2019/03749A patent/ZA201903749B/en unknown
- 2019-06-12 CL CL2019001623A patent/CL2019001623A1/es unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002067926A1 (en) * | 2001-02-27 | 2002-09-06 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating movement disorders |
| WO2006112685A1 (en) * | 2005-04-22 | 2006-10-26 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| WO2014142518A1 (en) * | 2013-03-12 | 2014-09-18 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in preventing or treating a movement disorder |
Also Published As
| Publication number | Publication date |
|---|---|
| KR102635941B1 (ko) | 2024-02-13 |
| KR20190087573A (ko) | 2019-07-24 |
| MY198417A (en) | 2023-08-29 |
| RU2019121914A (ru) | 2021-01-15 |
| IL267191B1 (en) | 2023-01-01 |
| CN110267657A (zh) | 2019-09-20 |
| CA3046300A1 (en) | 2018-06-21 |
| MX2019006941A (es) | 2019-09-06 |
| CN110267657B (zh) | 2022-12-13 |
| CL2019001623A1 (es) | 2019-08-23 |
| EP3556364B1 (en) | 2025-08-27 |
| AU2017374459B2 (en) | 2023-04-27 |
| EP3556364A1 (en) | 2019-10-23 |
| JP2020502137A (ja) | 2020-01-23 |
| BR112019012000A2 (pt) | 2019-10-29 |
| RU2019121914A3 (enExample) | 2021-04-21 |
| ZA201903749B (en) | 2022-01-26 |
| US11033531B2 (en) | 2021-06-15 |
| EP3556364A4 (en) | 2020-06-17 |
| AU2017374459A1 (en) | 2019-07-04 |
| MX391363B (es) | 2025-03-21 |
| WO2018111009A1 (ko) | 2018-06-21 |
| ES3039979T3 (en) | 2025-10-28 |
| JP7086076B2 (ja) | 2022-06-17 |
| US20190336481A1 (en) | 2019-11-07 |
| IL267191A (enExample) | 2019-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7737367B2 (ja) | α１Ａ－ＡＲ部分アゴニストを用いて神経障害を治療するための方法 | |
| JP2019516707A (ja) | 繊維筋痛又は繊維筋痛の関連する機能的症候群を予防又は治療するためのカルバメート化合物の使用 | |
| KR102693607B1 (ko) | 하지 불안 증후군을 치료하기 위한 치료제 | |
| AU2017374459B2 (en) | Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome | |
| JP2023085469A (ja) | 欠神発作又は欠神発作を示すてんかんの予防、軽減又は治療のためのカルバメート化合物の使用 | |
| AU2017374458B2 (en) | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder | |
| CA3046300C (en) | Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome | |
| RU2776368C2 (ru) | Применение карбаматного соединения для профилактики, облегчения или лечения треморов или синдрома тремора | |
| HK40015061A (en) | Use of carbamate compounds for preventing, alleviating, or treating tremors or tremor syndrome | |
| HK40015061B (en) | Use of carbamate compounds for preventing, alleviating, or treating tremors or tremor syndrome | |
| BR112019012000B1 (pt) | Uso de um composto de carbamato | |
| EP3556363B1 (en) | Use of carbamate compound for prevention, alleviation or treatment of pruritus | |
| US20220117941A1 (en) | Carbamate compound and use of formulation comprising same in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder | |
| RU2787771C2 (ru) | Применение карбаматного производного для предотвращения, облегчения или лечения малого эпилептического припадка или эпилепсии, проявляющей малый эпилептический припадок | |
| CA3081223C (en) | Use of carbamate compound for preventing, alleviating or treating absence seizure or epilepsy showing absence seizure | |
| HK40015213A (en) | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder |